HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
Chang HR, Nam S, Kook MC, Kim KT, Liu X, Yao H, Jung HR, Lemos R Jr, Seo HH, Park HS, Gim Y, Hong D, Huh I, Kim YW, Tan D, Liu CG, Powis G, Park T, Liang H, Kim YH.
Chang HR, et al.
Gut. 2016 Jan;65(1):19-32. doi: 10.1136/gutjnl-2014-307918. Epub 2014 Nov 19.
Gut. 2016.
PMID: 25410163
Free PMC article.